Treatment of short saphenous varicose vein using Endovenous Laser Ablation (EVLA) and Radiofrequency Ablation (RFA)

Comparison of the efficacy and complications of Endovenous Laser Therapy (EVLT) and Radiofrequency Ablation (RFA) in the treatment of short saphenous varicose veins

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170614034531N3

Enrollment

Registered

2024-12-30

Start date

2025-01-20

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose veins of the short saphenous vein. Injury of lesser saphenous vein at lower leg level

Interventions

Intervention 1: Intervention Group 1: Endovenous Laser Ablation (EVLA) is a modern and minimally invasive method for treating varicose veins, designed to reducing symptoms related to venous insufficie

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients eligible for the study include adults aged 18 and older diagnosed with short saphenous varicose veins through clinical examination and Doppler ultrasound, who are experiencing related symptoms and are candidates for endovenous thermal ablation therapy, and who are willing to provide informed consent

Exclusion criteria

Exclusion criteria: Previous Treatments: Patients who have undergone previous surgical or thermal ablation treatments for the same condition. Comorbidities: Individuals with significant comorbidities that may interfere with treatment outcomes or complicate the procedure (e.g., severe cardiovascular disease, uncontrolled diabetes). pregnancy: Pregnant or breastfeeding women. Allergies: Known allergies to materials used in the procedures (e.g., anesthetics, contrast agents). Infection: Presence of active infection in the affected limb or systemic infection. Anatomical Variations: Significant anatomical variations or abnormalities that may affect the procedure's success or safety. Non-compliance: Patients unable or unwilling to comply with follow-up assessments or study protocols.

Design outcomes

Primary

Measure	Time frame
Re-channeling. Timepoint: One week, 6 months and one year after intervention. Method of measurement: Sonography.;Persistence of reflux. Timepoint: One week, 6 months and one year after intervention. Method of measurement: Sonography.;Recurrence of reflux. Timepoint: One week, 6 months and one year after intervention. Method of measurement: Sonography.;Repeat treatment. Timepoint: One week, 6 months and one year after intervention. Method of measurement: Sonography.;Sural nerve injury. Timepoint: One week, 6 months and one year after intervention. Method of measurement: Sonography.	—

Measure

Time frame

Re-channeling. Timepoint: One week, 6 months and one year after intervention. Method of measurement: Sonography.;Persistence of reflux. Timepoint: One week, 6 months and one year after intervention. Method of measurement: Sonography.;Recurrence of reflux. Timepoint: One week, 6 months and one year after intervention. Method of measurement: Sonography.;Repeat treatment. Timepoint: One week, 6 months and one year after intervention. Method of measurement: Sonography.;Sural nerve injury. Timepoint: One week, 6 months and one year after intervention. Method of measurement: Sonography.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiki Tadayyon

Shahid Beheshti University of Medical Sciences

laser.cntr@yahoo.com+98 21 25719

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026